Device-associated infection rates in adult and pediatric intensive care units of hospitals in Egypt. International Nosocomial Infection Control Consortium (INICC) findings

Device-associated infections in the pediatric intensive care unit at the American University of Beirut Medical Center

“…In a Peruvian PICU, the rates of BSIs, VAPs and UTIs were 18.1 per 1,000 central venous catheter (CVC)-days, 7.9 per 1,000 endotracheal tube (ETT)-days, and 5.1 per 1,000 urinary catheter-days respectively [13]. The findings of the INICC in Egypt from two PICUs were 22.8 DAHAIs per 1,000 ICU-days, 18.8 CLABSIs per 1,000 line-days, and 31.8 VAPs per 1,000 ventilator-days [14]. In a Tunisian PICU, the rate of CVC-associated infections was 14.8 per 1,000 catheter-days [15].…”

Incidence of Nosocomial Blood Stream Infection, Pneumonia and Urinary Tract Infection Inpediatric Ward at King Abdulaziz University Hospital, Jeddah, Saudi Arabia 2015- 2016.

“…Study of 911 cases was performed at St Louis Children's Hospital, showed thatpatients with bloodstream infection were more likely to have multiple central venouscatheters (14).On the other hand, in Egypt, there is a study conducted in devises associated infection, they found that the Patients who are on mechanical ventilation device, central venous line, or urinary catheter are at higher risk to develop NI (6). But in our study we found that Patients who are on central venous line, peripherally inserted catheter and Nasogastric tube are at higher risk to develop NI.…”

“…Patients who are on mechanical ventilation device, central venous line, or urinary catheter are at higher risk to develop NI. (6) In Tunisia, a prospective cohort study was done and showed over all incidence of NI is (6.5%), mostly caused by Gram-negative bacteria (68%) with Klebsiella pneumonia accounting (22.7%), the commonest type is BSI (7). On the other hand, in a multicenter European prospective study showed that the overall incidence of NI is (2.5%), mostly caused by bacteria accounting for (68%).…”

Ventilator-Associated Pneumonia (VAP): Clinical Strategies, Treatment Challenges and Economic Concerns

“…A similar review revealed higher rates in lower-center salary contrasted with upper-center wage nations. Significantly high incidences were observed from India i.e., 36.2% and Egypt as 31.8/1000 ventilator-days [12,13]. While a lower frequency was reported from USA and Germany [14][15][16].…”

“…The growing incidence of multi-resistant organisms in VAP and the mortality benefit related with initial appropriate treatment have emerged to an amplified use of wide spectrum antibiotics [13][14][15][16]. The requirement to balance such factors with augmented selection pressure for the resistance emergence has led to the development of the appropriate guidelines to optimize the diagnosis, treatment and management of VAP based on local patterns of susceptibility [17][18][19][20].…”